Incheon, South Korea

Hyun Jong Lee

This inventor holds 1 USPTO granted patent. Top assignee: Abclon Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyun Jong Lee. Retrieved from https://idiyas.com/inventor/hyun-jong-lee-glhyyud2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyun Jong Lee: Innovator in Protein Purity

Introduction

Hyun Jong Lee is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that enhance protein purity and affinity for antigens.

Latest Patents

Hyun Jong Lee holds a patent titled "Polypeptide Improved in Protein Purity and Affinity for Antigen, Conjugate Thereof with Antibody or Antigen-Binding Fragment, and Preparation Method Therefor." This innovative work showcases his expertise in creating advanced biotechnological solutions.

Career Highlights

Currently, Hyun Jong Lee is associated with Abclon Inc., where he continues to push the boundaries of research and development in his field. His work at the company reflects his commitment to advancing biopharmaceutical technologies.

Collaborations

Hyun Jong Lee collaborates with Jong Ho Lee, further enhancing the innovative capabilities within their team. Their partnership exemplifies the synergy that can lead to groundbreaking advancements in biotechnology.

Conclusion

Hyun Jong Lee's contributions to the field of biotechnology, particularly through his patent and work at Abclon Inc., highlight his role as a key innovator. His efforts in improving protein purity and affinity for antigens are paving the way for future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…